Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
1. 请及时下载文件确认是否正确, 系统将在 2025-07-31 10:47:20 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: DOI: 10.1016/S0140-6736(23)00464-6
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0140673623004646
其他信息:
出版社: Elsevier BV
作者: Harry P Erba; Pau Montesinos; Hee-Je Kim; Elżbieta Patkowska; Radovan Vrhovac; Pavel Žák; Po-Nan Wang; Tsvetomir Mitov; James Hanyok; Yasser Mostafa Kamel; Jaime E Connolly Rohrbach; Li Liu; Aziz Benzohra; Arnaud Lesegretain; Jorge Cortes; Alexander E Perl; Mikkael A Sekeres; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Mark J Levis; Richard F Schlenk
